News in brief: Tilray launches pastilles; InhaleRx progress panic disorder trial by Steve Jones April 22, 2025April 22, 2025 Tilray Medical has launched pastilles into the Australian market for the first time. Three medicines, each […]
SAS-B approvals hit second highest on record as Tassie shows surprise growth by Steve Jones April 2, 2025April 2, 2025
Althea blames medical sales decline on TGA ‘falling asleep at the wheel’ amid ‘crazy’ antics of competitors by Steve Jones March 21, 2025March 26, 2025
Two-month total of SAS-B approvals up 47% on 2024, TGA data shows by Steve Jones March 4, 2025April 1, 2025
Pastilles drive Bioxyne to first-half profit after revenue climbs 171% by Steve Jones March 3, 2025March 3, 2025
Growth of pastilles accelerates as SAS approvals get off to strong start in 2025 by Steve Jones February 17, 2025February 17, 2025
Bioxyne sees sharp revenue growth as shares jump after strong quarter by Steve Jones October 17, 2024February 25, 2025
Pastilles gaining in popularity as SAS-B approvals maintain strong start to 2024 by Steve Jones May 6, 2024July 16, 2024
Vape carts and pastilles on the rise but flower to remain dominant format by Steve Jones March 14, 2024July 16, 2024
